Authors/Disclosures
|
Michael D. Geschwind, MD, PhD, FÂ鶹´«Ã½Ó³»
|
Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainstorm Cell Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Walter Grubb. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reata Pharmaceuticals, Inc.. |
|
Benjamin Raudabaugh
(UCSF)
|
No disclosure on file |
|
Aissatou Haman
|
No disclosure on file |
|
Holli A. Horak, MD, FÂ鶹´«Ã½Ó³»
(University of Arizona)
|
Dr. Horak has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with FDA. Dr. Horak has a non-compensated relationship as a Finance Committee member with Â鶹´«Ã½Ó³»EM that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
|
Gillian Devereux
|
No disclosure on file |
|
|
No disclosure on file |
|
Charles Torres-Chae
(University of California San Francisco)
|
No disclosure on file |
|
Amy Kuo
|
No disclosure on file |
|
Bruce L. Miller, MD, FÂ鶹´«Ã½Ó³»
(University of California, San Francisco)
|
Dr. Miller has nothing to disclose. |